Magnesium Supplementation Stimulates Autophagy to Reduce Lipid Accumulation in Hepatocytes via the AMPK/mTOR Pathway

• Published in: Biological trace element research 2023-07, Vol.201 (7), p.3311-3322
• Main Authors: Chen, Shiyan, Luo, Shunkui, Zou, Baojia, Xie, Jianhui, Li, Jian, Zeng, Yingjuan
• Format: Article
• Language: English
• Subjects: Accumulation; AMP-Activated Protein Kinases; Autophagy; Biochemistry; Biomedical and Life Sciences; Biotechnology; Cell survival; cell viability; Deposition; Dietary Supplements; Diseases; Fatty acids; Fatty Acids, Nonesterified - metabolism; Fatty Acids, Nonesterified - pharmacology; Fatty Acids, Nonesterified - therapeutic use; Fatty liver; free fatty acids; Hepatocytes; Humans; Life Sciences; Lipid Metabolism; Lipid peroxidation; Lipids; Liver; Liver - metabolism; Liver diseases; Magnesium; Magnesium - metabolism; Metabolic disorders; Metabolic syndrome; Metabolism; Non-alcoholic Fatty Liver Disease - drug therapy; Nutrition; Obesity; Obesity - metabolism; Oncology; Oxidation; Signal Transduction; Supplements; Survival; Therapeutic applications; therapeutics; TOR protein; TOR Serine-Threonine Kinases - metabolism; Western blotting
• ISSN: 0163-4984; 1559-0720
• DOI: 10.1007/s12011-022-03438-6

Metabolic-associated fatty liver disease (MAFLD) (previously known as nonalcoholic fatty liver disease (NAFLD)) is a disease with high worldwide prevalence, but with limited available therapeutic interventions. Autophagy is a cell survival mechanism for clearing excess lipids in hepatocytes and affects the occurrence and development of MAFLD. In addition, some studies have shown that magnesium deficiency is common in patients with obesity and metabolic syndrome. Magnesium supplementation can effectively improve metabolism-related diseases such as obesity and fatty liver. Our study successfully constructed a cellular model of MAFLD by 1 mM free fatty acid (FFA) intervention in LO2 cells for 24 h, and there was an increase in lipid accumulation in hepatocytes after FFA intervention. Magnesium supplementation was shown to reduce lipid deposition in hepatocytes induced by FFA, and Western blotting (WB) analysis showed that magnesium supplementation could downregulate the expression of Fasn and SREBP1 and increase the expression of LPL, suggesting that magnesium can reduce lipid accumulation by reducing lipid synthesis and increasing lipid oxidation. Magnesium supplementation could affect cellular lipid metabolism by activating the AMPK/mTOR pathway to stimulate autophagy. Our results identified a relationship between magnesium and lipid accumulation in hepatocytes and showed that magnesium supplementation reduced lipid deposition in hepatocytes by activating autophagy by activating the AMPK-mTOR pathway.